Body composition analysis is the process to evaluate the amount of fat, muscle, and bone in the body. It gives the precise measurement of body fat in relation to lean body mass. Evaluation of body composition is essential in order to determine the risks associated with high or low levels of body fat.
The growth of the overall body composition analyzers market can be contributed to rise in obese population across the globe, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements. In the coming years, the body composition analyzers market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global body composition analyzers market. However, inconsistency in the accuracy of different analyzers and high cost of equipment is likely to restrain the growth of the market during the forecast period.
Thebody composition analyzer markethas been segmented, on the basis of product type, into Bio-impedance analyzers, Dual energy X-ray absorptiometry (DEXA), Skinfold calipers, Air displacement plethysmography (ADP), and Hydrostatic weighing. The bio-impedance analyzers segment is expected to command the largest share of the global body composition analyzers market. The large share of the bio-impedance analyzers segment can be attributed to the benefits of these products over other body composition analyzers, such as easy operations, low cost, and better accuracy.
Key players in this market include Tanita Corporation (Japan), Omron Corporation (Japan), InBody Co., Ltd (South Korea), Hologic, Inc. (U.S.) and GE Healthcare (U.S.) among others. These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.
